International Journal of Clinical Pharmacy

, Volume 35, Issue 4, pp 593–599 | Cite as

The use of a low dose hydrocortisone to prevent pulmonary embolism in patients with multiple trauma

  • Anis ChaariEmail author
  • Hatem Ghadhoune
  • Olfa Chakroune
  • Hanen Abid
  • Olfa Turki
  • Mabrouk Bahloul
  • Mounir Bouaziz
Research Article


Background Venous thromboembolism events are common in trauma patients. Immediate acute inflammation following injury triggers coagulation cascade and may increase the risk of pulmonary embolism (PE) in this population. Objective We aimed to evaluate whether early low-dose steroids prevent symptomatic PE onset in multiple trauma patients. Setting The medical surgical intensive care unit of Habib Bourguiba University Hospital (Sfax—Tunisia). Methods Comparative study of two cohorts: a retrospective cohort of patients who didn’t receive early low-dose steroids (steroid (−) group) and a prospective cohort of patients who received hydrocortisone with a dose of 100 mg/8 h for a scheduled period of 7 days (steroid (+) group). All adult patients admitted in our intensive care unit (ICU) for multiple trauma with predicted duration of mechanical ventilation over 48 h were included. Main outcome measure Evaluation of the impact of low-dose steroids on the incidence of symptomatic PE. Results We included 175 patients: 92 in the steroids (−) group and 83 in the steroids (+) group. PE was diagnosed in 15 patients (8.5 %). The incidence of PE was significantly lower in steroid (+) group (3.6 vs 13 %; p = 0.013). In multivariate analysis, independent factors predicting PE onset were meningeal hemorrhage [OR = 14.7; 95 % CI (2.2–96.3); p = 0.013] and pelvic ring trauma [OR = 8; 95 % CI (1.8–36.4); p = 0.007] whereas low-dose steroids were significantly associated with a protective effect [OR = 0.2; 95 % CI (0.05–0.77); p = 0.019]. There was no significant difference between steroids (+) and steroids (−) groups neither in terms of mean ICU length of stay (LOS) (respectively 11 ± 9.7 and 12.3 ± 10.7 days; p = 0.372) nor in terms of ICU mortality (respectively 29.3 and 24.1 %; p = 0.434). Conclusion Steroids are effective in reducing the incidence of PE in multiple trauma patients. However, no significant benefice was found on ICU mortality.


Hydrocortisone Multiple trauma Pulmonary embolism 



We thank Dr Mariam El Habib for her assistance in elaborating the manuscript.



Conflicts of interest



  1. 1.
    Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet. 1997;349(9063):1436–42.PubMedCrossRefGoogle Scholar
  2. 2.
    Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 1996;335(10):701–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Schultz DJ, Brasel KJ, Washington L, et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J Trauma. 2004;56(4):727–31.PubMedCrossRefGoogle Scholar
  4. 4.
    Knudson MM, Ikossi DG. Venous thromboembolism after trauma. Curr Opin Crit Care. 2004;10(6):539–48.PubMedCrossRefGoogle Scholar
  5. 5.
    Blann AD, Lip GY. Virchow’s triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets. Thromb Res. 2001;101(4):321–7.PubMedCrossRefGoogle Scholar
  6. 6.
    Muehlstedt SG, Richardson CJ, Lyte M, Rodriguez JL. Systemic and pulmonary effector cell function after injury. Crit Care Med. 2002;30(6):1322–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Heesen M, Deinsberger W, Dietrich GV, et al. Increase of interleukin-6 plasma levels after elective craniotomy: influence of interleukin-10 and catecholamines. Acta Neurochir. 1996;138(1):77–80.PubMedCrossRefGoogle Scholar
  8. 8.
    Gando S, Sawamura A, Hayakawa M. Trauma, shock, and disseminated intravascular coagulation: lessons from the classical literature. Ann Surg. 2011;254(1):10–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Roquilly A, Mahe PJ, Seguin P, et al. Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA. 2011;305(12):1201–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care, AANS/CNS, Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. XV. Steroids. J Neurotrauma. 2007;24 Suppl:S91–5.Google Scholar
  11. 11.
    Chin P, Hurrell M, McGregor D, Beckert L. The role of CT pulmonary angiography in patients with suspected pulmonary embolism admitted to general medicine. N Z Med J. 2006;119:U2052.PubMedGoogle Scholar
  12. 12.
    Jaff MR, McMurtry MS, Archer SL, American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, American Heart Association Council on Peripheral Vascular Disease, American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation. 2011;123(16):1788–830.PubMedCrossRefGoogle Scholar
  13. 13.
    Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957–63.PubMedCrossRefGoogle Scholar
  14. 14.
    Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707–10.PubMedCrossRefGoogle Scholar
  15. 15.
    Baker SP, O’Neill B, Haddon W Jr, Long WB. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14(3):187–96.PubMedCrossRefGoogle Scholar
  16. 16.
    Reiff DA, Haricharan RN, Bullington NM, et al. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis. J Trauma. 2009;66(5):1436–40.PubMedCrossRefGoogle Scholar
  17. 17.
    Knudson MM, Ikossi DG. Venous thromboembolism after trauma. Curr Opin Crit Care. 2004;10:539–48.PubMedCrossRefGoogle Scholar
  18. 18.
    Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 1996;335:701–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Bahloul M, Chaari A, Dammak H, et al. Post-traumatic pulmonary embolism in the intensive care unit. Ann Thorac Med. 2011;6(4):199–206.PubMedCrossRefGoogle Scholar
  20. 20.
    Antunes AA, Sotomaior VS, Sakamoto KS, et al. Interleukin-6 plasmatic levels in patients with head trauma and intracerebral hemorrhage. Asian J Neurosurg. 2010;5(1):68–77.PubMedGoogle Scholar
  21. 21.
    Ziebell JM, Morganti-Kossmann MC. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics. 2010;7(1):22–30.PubMedCrossRefGoogle Scholar
  22. 22.
    Majetschak M, Christensen B, Obertacke U, et al. Sex differences in posttraumatic cytokine release of endotoxin-stimulated whole blood: relationship to the development of severe sepsis. J Trauma. 2000;48(5):832–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Hergenroeder GW, Moore AN, McCoy JP Jr et al. Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation. 2010;7:7–19.Google Scholar
  24. 24.
    Van Aken BE, den Heijer M, Bos GM, et al. Recurrent venous thrombosis and markers of inflammation. Thromb Haemost. 2000;83(4):536–9.PubMedGoogle Scholar
  25. 25.
    Owings JT, Kraut E, Battistella F, et al. Timing of the occurrence of pulmonary embolism in trauma patients. Arch Surg. 1997;132(8):862–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Malerba G, Romano-Girard F, Cravoisy A, et al. Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation. Intensive Care Med. 2005;31(3):388–92.PubMedCrossRefGoogle Scholar
  27. 27.
    Vinclair M, Broux C, Faure P, et al. Duration of adrenal inhibition following a single dose of etomidate in critically ill patients. Intensive Care Med. 2008;34(4):714–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Anis Chaari
    • 1
    • 4
    Email author
  • Hatem Ghadhoune
    • 1
  • Olfa Chakroune
    • 2
  • Hanen Abid
    • 3
  • Olfa Turki
    • 1
  • Mabrouk Bahloul
    • 1
  • Mounir Bouaziz
    • 1
  1. 1.Intensive Care Unit DepartmentFaculté de médecine de SfaxSfaxTunisia
  2. 2.Emergency DepartmentFaculté de médecine de SfaxSfaxTunisia
  3. 3.Radiology DepartmentFaculté de médecine de SfaxSfaxTunisia
  4. 4.Service de Réanimation médicaleHôpital Habib BourguibaSfaxTunisia

Personalised recommendations